SARS-CoV-2 N binds MAVS

Stable Identifier
R-HSA-9755747
Type
Reaction [binding]
Species
Homo sapiens
Related Species
Severe acute respiratory syndrome coronavirus 2
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
SARS-CoV-2 nucleocapsid protein (N) can undergo liquid-liquid phase separation (LLPS) with RNA (Wu Y et al. 2021; Wang S et al. 2021; Cubuk J et al. 2021; Lu S et al. 2021). SARS-CoV-2 N:RNA LLPS recruits mitochondrial antiviral-signaling protein (MAVS) and downregulates MAVS-dependent induction of type I interferon (IFN) (Wang S et al. 2021). The dimerization domain (DD) of viral N is essential for LLPS and dampening MAVS-mediated type I interferon (IFN) production in mammalian cells. Deletion of DD or targeting it by inhibitors almost completely abolished SARS-CoV-2 N LLPS and enhanced the innate antiviral response both in vitro and in vivo (Wang S et al. 2021).

Co-immunoprecipitation experiments showed interactions between SARS-CoV-2 N and human MAVS upon co-expression of tagged proteins in human embryonic kidney 293T cells (HEK293T cells). Endogenous MAVS immunoprecipitated together with N in human epithelial Caco-2 cells infected with SARS-CoV-2. Overexpression of N negatively regulated activation of TBK1 and IRF3 and suppressed interactions of endogenous MAVS with endogenous TRIM31 and DDX58 (RIG-I) in Sendai virus (SeV)-stimulated HEK293T and human lung carcinoma A549 cells. In addition, tandem ubiquitin-binding entities (TUBE)-based pull-down method showed that expression of N strongly inhibited K63-linked polyubiquitination of MAVS in SeV-stimulated HEK293T and A549 cells. MAVS aggregation was also impaired by viral N. Further, acetylation by host CREB-binding protein (CREBBP, CBP) at Lys375 of viral N abrogates its LLPS and the N-mediated suppression of MAVS signaling (Wang S et al. 2021). Overall, the data suggest that SARS-CoV-2 N:RNA LLPS inhibits MAVS-mediated production of type I and III IFNs by preventing the formation of the MAVS signalosome complex.

Literature References
PubMed ID Title Journal Year
34239064 Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity

Zhou, F, Lou, L, Dai, T, Yang, B, Zhang, L, Wang, S, Huang, H, Chu, F, Qin, Z, Lu, H, Pan, T

Nat Cell Biol 2021
Participants
Participates
This event is regulated
Disease
Name Identifier Synonyms
COVID-19 DOID:0080600 2019 Novel Coronavirus (2019-nCoV), Wuhan seafood market pneumonia virus infection, 2019-nCoV infection, Wuhan coronavirus infection
Authored
Reviewed
Created
Cite Us!